We immunohistochemically examined SOX4 and p16 expression (which have been implicated in ATLL carcinogenesis) in 11 ATLL patients and 20 PTCL-NOS patients and classified them into four stages according to the percentage of positive cells. Here, CDKN2A is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.